Type 1 Diabetes News

November 3, 2014November 3, 2014

Artificial Pancreas Clinical Trial Enabled by NIH Grant

An artificial pancreas, the ultimate cure for type 1 diabetes, will be tested in clinical trials as a result of a $1 million National Institutes of Health Grant awarded to Dr. B. ... Read more

October 28, 2014October 28, 2014

License For Insuline-Producing Cells Brings Nuvilex, Inc. Closer To “Bio-Artificial Pancreas” To Treat Type 1 Diabetes

News, Type 1 Diabetes News

Nuvilex, Inc. plans to develop a diabetes treatment using its Cell-in-a-Box® platform technology. In 2013, the company acquired the exclusive worldwide rights to the cellulose-based-live-cell encapsulation technology usage, becoming well positioned to develop ... Read more

October 21, 2014October 21, 2014

Enterovirus Infection Could Lead to Type 1 Diabetes, Study Shows

News, Type 1 Diabetes News

A recently concluded study by a team of researchers from China Medical University looked into the potential causal relationship between a prior enterovirus infection and the development of type 1 diabetes ... Read more

October 17, 2014October 17, 2014

Canadian Associations Host 17th Professional Conference on Diabetes

News, Type 1 Diabetes News, Type 2 Diabetes News

The Canadian Diabetes Association (CDA) is collaborating with the Canadian Society of Endocrinology and Metabolism (CSEM) to host the 17th Professional Conference and Annual Meetings, which is taking place in ... Read more

October 14, 2014October 14, 2014

Researchers Make Major Discovery Into Type 1 Diabetes

News, Type 1 Diabetes News

A new study entitled “Generation of Functional Human Pancreatic β Cells In Vitro” published in online October issue of Cell reports a new method capable of generating functional insulin-producing pancreatic ... Read more

October 7, 2014October 7, 2014

Childhood Diabetes May Be Triggered in Utero By Viral infection

News, Type 1 Diabetes News

A new study contributing to a better understanding of type 1 childhood diabetes, entitled “Antibodies to islet cell auto antigens, rotaviruses and/or enteroviruses in cord blood and healthy mothers in ... Read more

October 6, 2014October 6, 2014

Scientists Highlight Molecular Mechanism in Diabetes

News, Type 1 Diabetes News, Type 2 Diabetes News

A group of scientists from the University of Auckland (New Zealand) may have recently discovered a major advance in diabetes research by uncovering what they believe to be the molecular mechanism that ... Read more

September 17, 2014September 17, 2014

New Insulin From Novo Nordisk Reveals Long-Term Efficacy in Both Children and Adolescents

News, Type 1 Diabetes News

Novo Nordisk released new data from the clinical trial, BEGIN YOUNG 1, a study comparing a once-daily Tresiba (insulin degludec) regime, an ultralong-acting basal insulin analogue, with an insulin detemir regime, ... Read more

September 11, 2014September 11, 2014

Lilly’s Basal Insulin Peglispro Outperforms Lantus® in HbA1c Superiority in Phase III Trials For Type 1 Diabetes

News, Type 1 Diabetes News

Eli Lilly and Company recently reported that its IMAGINE-1 and IMAGINE-3 Phase III clinical trials showed that basal insulin peglispro (BIL) treatment induces a statistically significant lower hemoglobin A1c (HbA1c, glycated haemoglobin), a ... Read more

September 8, 2014September 8, 2014

FDA Accepts Investigational Drug VC-01 For New Type 1 Diabetes Clinical Trial

News, Type 1 Diabetes News

ViaCyte, a private regenerative medicine drug developer, has recently announced that the U.S. Food and Drug Administration’s acceptance of a clinical trial protocol to test the company’s candidate product, VC-01, ... Read more